These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23104931)

  • 21. Salivary flow rate in patients with schizophrenia on clozapine.
    Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK
    Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal agranulocytosis 4 years after discontinuation of clozapine.
    Tiihonen J
    Am J Psychiatry; 2006 Jan; 163(1):161. PubMed ID: 16390912
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapine.
    Schmidinger S; Hofer A
    J Clin Psychopharmacol; 2014 Jun; 34(3):385-7. PubMed ID: 24717250
    [No Abstract]   [Full Text] [Related]  

  • 24. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine-induced oculogyric crises.
    Chakraborty R; Chatterjee A
    Ann Pharmacother; 2007 Nov; 41(11):1916. PubMed ID: 17925499
    [No Abstract]   [Full Text] [Related]  

  • 26. [No given alternatives to clozapine in treatment-resistant schizophrenia].
    Eriksen J; Rosenborg S
    Lakartidningen; 2013 Oct 9-15; 110(41):1809. PubMed ID: 24187896
    [No Abstract]   [Full Text] [Related]  

  • 27. Clozapine-induced myocarditis.
    Caetano D; Gandhi C
    Aust N Z J Psychiatry; 2008 May; 42(5):434-5. PubMed ID: 18499933
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma.
    Li TM; Chung CT; Wei IH; Huang CC
    J Clin Psychopharmacol; 2012 Dec; 32(6):835-6. PubMed ID: 23131888
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?
    Blackman G; Oloyede E; Horowitz M; Harland R; Taylor D; MacCabe J; McGuire P
    Schizophr Bull; 2022 Jan; 48(1):176-189. PubMed ID: 34651184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
    Kinzie E; Meltzer-Brody S
    Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
    [No Abstract]   [Full Text] [Related]  

  • 33. [Maintenance therapy with low doses of clozapine in schizophrenia].
    Lisulov R; Nedić A
    Med Pregl; 1995; 48(1-2):15-8. PubMed ID: 8657050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine treatment associated with increased risk of acute myeloid leukemia (AML).
    Nielsen J; Boysen A
    Schizophr Res; 2010 Nov; 123(2-3):270-2. PubMed ID: 20850952
    [No Abstract]   [Full Text] [Related]  

  • 35. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations from 8 cases of clozapine rechallenge after development of myocarditis.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; McNeil JJ
    J Clin Psychiatry; 2012 Feb; 73(2):252-4. PubMed ID: 22401481
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterogeneity of clozapine-associated myocarditis: An opportunity for novel preventing strategies.
    Baptista T; Rojas N; Dávila DF
    Aust N Z J Psychiatry; 2015 Nov; 49(11):1068. PubMed ID: 25972407
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.
    Tanríverdi N; Yazící KM
    Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.